IDEAS home Printed from https://ideas.repec.org/f/pne341.html
   My authors  Follow this author

Margherita Neri

Personal Details

First Name:Margherita
Middle Name:
Last Name:Neri
Suffix:
RePEc Short-ID:pne341
[This author has chosen not to make the email address public]

Research output

as
Jump to: Working papers Articles

Working papers

  1. Margherita Neri;Adrian Towse;Martina Garau, 2018. "Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward," Briefing 002084, Office of Health Economics.
  2. Margherita Neri;Adrian Towse, 2017. "Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help?," Briefing 001922, Office of Health Economics.
    repec:ohe:respap:002208 is not listed on IDEAS
    repec:ohe:conrep:002386 is not listed on IDEAS
    repec:ohe:respap:002040 is not listed on IDEAS
    repec:ohe:conrep:002282 is not listed on IDEAS
    repec:ohe:conrep:002380 is not listed on IDEAS
    repec:ohe:conrep:002322 is not listed on IDEAS
    repec:ohe:respap:002293 is not listed on IDEAS

Articles

  1. Eleanor Bell & Margherita Neri & Lotte Steuten, 2022. "Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward," Applied Health Economics and Health Policy, Springer, vol. 20(1), pages 105-117, January.
  2. Margherita Neri & Patricia Cubi-Molla & Graham Cookson, 2022. "Approaches to Measure Efficiency in Primary Care: A Systematic Literature Review," Applied Health Economics and Health Policy, Springer, vol. 20(1), pages 19-33, January.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Margherita Neri;Adrian Towse;Martina Garau, 2018. "Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward," Briefing 002084, Office of Health Economics.

    Cited by:

    1. Michaeli, Daniel Tobias & Mills, Mackenzie & Kanavos, Panos, 2022. "Value and price of multi-indication cancer drugs in the USA, Germany, France, England, Canada, Australia, and Scotland," LSE Research Online Documents on Economics 115720, London School of Economics and Political Science, LSE Library.
    2. Daniel Tobias Michaeli & Mackenzie Mills & Panos Kanavos, 2022. "Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland," Applied Health Economics and Health Policy, Springer, vol. 20(5), pages 757-768, September.
    3. Carlos Campillo-Artero & Jaume Puig-Junoy & José Luis Segú-Tolsa & Marta Trapero-Bertran, 2020. "Price Models for Multi-indication Drugs: A Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 18(1), pages 47-56, February.
    4. Rosella Levaggi & Paolo Pertile, 2020. "Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition," Applied Health Economics and Health Policy, Springer, vol. 18(3), pages 357-362, June.

Articles

  1. Eleanor Bell & Margherita Neri & Lotte Steuten, 2022. "Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward," Applied Health Economics and Health Policy, Springer, vol. 20(1), pages 105-117, January.

    Cited by:

    1. Brassel, Simon & Al Taie, Amer & Steuten, Lotte, 2023. "Value assessment of antimicrobials using the STEDI framework – How steady is the outcome?," Health Policy, Elsevier, vol. 136(C).

  2. Margherita Neri & Patricia Cubi-Molla & Graham Cookson, 2022. "Approaches to Measure Efficiency in Primary Care: A Systematic Literature Review," Applied Health Economics and Health Policy, Springer, vol. 20(1), pages 19-33, January.

    Cited by:

    1. Fang Wu & Wei Chen & Lingling Lin & Xu Ren & Yingna Qu, 2022. "The Balanced Allocation of Medical and Health Resources in Urban Areas of China from the Perspective of Sustainable Development: A Case Study of Nanjing," Sustainability, MDPI, vol. 14(11), pages 1-28, May.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 5 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (4) 2018-05-21 2019-09-30 2020-08-31 2021-11-08. Author is listed
  2. NEP-COM: Industrial Competition (1) 2018-10-15
  3. NEP-IAS: Insurance Economics (1) 2021-11-08
  4. NEP-INO: Innovation (1) 2018-10-15
  5. NEP-TID: Technology and Industrial Dynamics (1) 2018-10-15

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Margherita Neri should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.